Veracyte is evolving into a self-funded cancer diagnostic platform, leveraging clinical evidence. Click here to read more ...

Veracyte’s core tests are Decipher and Afirma. Both of these tests are producing double-digit growth with improving margins.

Prostate cancer is projected to be the most commonly diagnosed cancer among men in the United States next year, and the ...

After treatment for metastatic prostate cancer, a drop in prostate-specific antigen (PSA) levels in the blood is an indicator ...

A blood test taken years before cancer appears may hold a warning sign for men’s long-term health.

After treatment for metastatic prostate cancer, a drop in prostate-specific antigen (PSA) levels in the blood is an indicator that the treatment is working.

In "Beyond Diagnosis: Metastatic Castration-Sensitive Prostate Cancer," Cleveland Clinic oncologist Christopher Wee, MD, and ...

Urologists debunk common prostate cancer myths about age, symptoms, PSA testing and treatment.